Fontolizumab
Top View
- (12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
- International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
- (INN) for Biological and Biotechnological Substances
- Dissecting the Heterogeneity in T-Cell Mediated Inflammation In
- New Targets for Mucosal Healing and Therapy in Inflammatory Bowel Diseases
- (12) United States Patent (10) Patent No.: US 9,677,055 B2 Jones Et Al
- WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
- (12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Tissue-Resident Γδt Cells As Gatekeepers of Psoriatic Skin Inflammation and Dietary Interventions
- Wo 2010/095940 A2
- Assessment of the Evolution of Cancer Treatment Therapies
- Scanning for Therapeutic Targets Within the Cytokine Network of Idiopathic Inflammatory Myopathies
- Customs Tariff - Schedule Xxi - 1
- T Lymphocytes in the Intestinal Mucosa: Defense and Tolerance
- Cytokine-Mediated Crosstalk Between Immune Cells and Epithelial Cells in the Gut
- Biologics in Inflammatory Bowel Disease
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances